CRVS Next Earnings Date Notes

— Corvus Pharmaceuticals (CRVS) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with cancer and autoimmune diseases. Their pipeline includes small molecule and antibody candidates targeting the adenosine pathway, which can suppress immune system activity in the tumor microenvironment, and precision immunotherapy assets. Key assets include mupadolimab (anti-CD73 antibody) and ciforadenant (an A2A receptor antagonist), which are being explored in various settings, including non-small cell lung cancer and immune-mediated diseases. For investors, the most important business metrics to watch are the progress of ongoing clinical trials, updates about patient enrollment and trial data readouts, available cash balance & cash runway, and partnership or collaboration milestones. Since CRVS does not currently generate product revenue, R&D expenses and burn rate are crucial, as they reflect the company’s ability to execute its pipeline strategy and remain solvent while advancing its lead candidates. Also, announcements about regulatory filings, trial initiations, or licensing agreements can significantly impact the company’s long-term outlook. As you prepare to listen to the upcoming earnings call, look for management commentary on these metrics and any adjustments to development timelines, as these will be key indicators of CRVS’s future prospects. The next projected earnings date for CRVS is 8/6/2026 after close (stay tuned for a confirmed earnings date once announced).

CRVS Next Earnings Date FAQ

On this page we presented the CRVS Next Earnings Date information for Corvus Pharma along with recent past earnings dates. For Q1 of 2026, CRVS reported earnings of -0.150/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, CRVS reported earnings of -0.150/share, with the earnings report taking place on 3/12/2026. For Q3 of 2025, CRVS reported earnings of -0.120/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, CRVS reported earnings of -0.100/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, CRVS reported earnings of -0.130/share, with the earnings report taking place on 5/8/2025. Based on these past earnings dates, the projected next earnings date for CRVS is 8/6/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Corvus Pharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Corvus Pharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Corvus Pharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next CRVS earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up CRVS's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the CRVS next earnings date.